Director, WW Medical Oncology, Thoracic Cancers

Working with Us
Challenging. Meaningful. Life-changing. Those aren’t words that are usually associated with a job. But working at Bristol Myers Squibb is anything but usual. Here, uniquely interesting work happens every day, in every department. From optimizing a production line to the latest breakthroughs in cell therapy, this is work that transforms the lives of patients, and the careers of those who do it. You’ll get the chance to grow and thrive through opportunities uncommon in scale and scope, alongside high-achieving teams. Take your career farther than you thought possible.

Bristol Myers Squibb recognizes the importance of balance and flexibility in our work environment. We offer a wide variety of competitive benefits, services and programs that provide our employees with the resources to pursue their goals, both at work and in their personal lives. Read more: careers.bms.com/working-with-us.

Position Summary

This role will have accountability as the WW Medical Director supporting the thoracic cancer book of work reporting to the Executive Director, Disease Area Head Thoracic and Head & Neck Cancers. The Medical Director will develop and drive execution of global medical affairs plans, congress plans, provide medical insight into strategic plans, and provide strategic direction in scientific communication to ensure delivery of key knowledge to the internal stakeholders including local medical market colleagues; ensure global alignment and input for the medical plan.
 

Key Responsibilities

The successful candidate will be primarily responsible for the development and execution of the Global Medical Affairs strategy for key thoracic assets in scope. This position includes the following responsibilities:

Core member of the Asset/Indication Medical Strategy team, contributing to:  

• Shaping global medical strategy with the cross functional team around key assets in scope

• Ensuring the asset/s are appropriately (co-)positioned and developed within the overall BMS disease area strategy in line with enterprise needs

• In line with Medical Product Leads and Disease Area Head direction, develop and execute the global medical strategy, scientific narratives, provide medical insight for Global Program Teams, commercial strategic plans, and provide strategic direction in medical communication efforts to ensure delivery of key knowledge to the internal stakeholders including local medical market colleagues; ensure alignment across global markets on medical strategy

• Responsible for developing asset/indication Integrated Evidence Plans - Lead workstreams to identify evidence gaps to address unmet needs and to define and support global execution of these opportunities. Develop prioritized Integrated Evidence Plans that conform to the Medical Value Framework for execution across modalities including Investigator sponsored research, Medical Affairs Sponsored Trials, RWD and Clinical Research Collaborations

• Collaborate with Medical Communications leads for the overall successful delivery of Global Medical Communications plans – Ensure workstreams are optimized in generating impactful strategies with respect to the medical communication plans including publications, scientific symposia, global independent medical education, internal training strategy as well as into commercialization brand plans.

• They will provide medical support for governance meetings, tumor CDTs and GPT, lead congresses execution, and advisory board meeting planning and execution; provide medical input for development of booths, congress materials, and standard response letters; and work with MedComms to support the execution of medcomms tactics (abstracts, manuscripts, and congress presentations). 

• They will partner closely with medical colleagues in the Markets, with Clinical Research, Regulatory, Commercial, Access, Health Outcomes, Publications, and other key functions.

• Cross collaborate with other disease area team members that have scope in tumor overlap to advise on development strategy as well as alignment overall with disease area strategy.

• Provide program highlights/updates to Department and/or corporate leadership as requested

• External Engagement and Advocacy: Maintain ongoing long-term collaborative peer-to-peer relationships with key global thought leaders and oversight over activities, including Advisory Boards, congress encounters, symposia speaking engagements and alignment with markets/other cross functional partners to ensure efficient and impactful KOL collaboration.

• <